TITLE

Dress to suppress

PUB. DATE
June 2007
SOURCE
Marketing Health Services;Summer2007, Vol. 27 Issue 2, p7
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article looks at hospital gowns with an antibacterial coating. The gowns were created by Fatima BA-Alawi from DCS Designs, a corporate spinoff from the University of Portsmouth in Great Britain. According to the article, the goal of the gowns is to decrease the spread of bacteria and infection. The Permagard coating, which is said to hamper the spread of drug-resistant bacteria, is provided by Carrington Career and Workwear. A trial evaluating the gowns will take place at a hospital in London, England.
ACCESSION #
25914852

 

Related Articles

  • Gowns, Scrubs & O.R. Apparel.  // Surgical Products;Mar2000, Vol. 19 Issue 5, p14 

    Features a selection of medical gowns, scrubs, and operating-room apparel. Splash-resistant gowns; Medical footwear; Masks; Surgical glove.

  • Clinical trial of extended-dose chloroquine for treatment of resistant falciparum malaria among Afghan refugees in Pakistan. Howard, Natasha; Durrani, Naeem; Sanda, Sanda; Beshir, Khalid; Hallett, Rachel; Rowland, Mark // Malaria Journal;2011 Supplement 1, Vol. 10 Issue Suppl 1, p171 

    Background: Falciparum malaria is a significant problem for Afghan refugees in Pakistan. Refugee treatment guidelines recommended standard three-day chloroquine treatment (25 mg/kg) for first episodes and extended five-day treatment (40 mg/kg) for recrudescent infections, based on the assumption...

  • White Goods. Dale, Shane // Wearables;Aug2009, Vol. 13 Issue 7, p30 

    The article presents questions and answers related to white goods, including what types of these goods are in demand, how important are fashion and performance features and what medical institutions are the best targets for these goods.

  • Medical protective gowns in Taiwan.  // Indian Textile Journal;Sep2003, Vol. 113 Issue 12, p177 

    Evaluates the line of medical protective gowns developed in conjunction with hospitals, textile companies and the government of Taiwan, developed by the China Textile Institute as of September 2003. Protective functions; Importance of research and development in the textile manufacturing...

  • Research & Markets: The Hospital Market For Surgical Gowns In France.  // Biomedical Market Newsletter;5/14/2011, p455 

    The article reports that Research & Markets Ltd. has announced the addition of the "The Hospital Market For Surgical Gowns in France" report to their offering. This report examines the hospital market for surgical gowns in France in 2008 and 2009. A distinction is made between those with...

  • EN13795 - Now published in the UK.  // International Journal of Therapy & Rehabilitation;May2007, Vol. 14 Issue 5, p8 

    The article reports that the part three of EN13795, an important European standard that relates to surgical drapes, gowns, and clean air suits, was published and made available on January 31, 2007 by the British Standards Institution (BSI). The said move is said to mean that trusts across Great...

  • ANOTHER SILENT KILLER. Bird, Maryann // Time International (South Pacific Edition);7/21/2003, Issue 28, p13 

    The article offers information about a large-scale clinical trial in Saude Manhiça, Mozambique, to test a GlaxoSmithKline PLC (GSK) malaria-vaccine called RTS,S/ASO2A. It is the most advanced of the 80 malaria-vaccine candidates now in development. In earlier tests, GSK's drug was found safe...

  • Natural Peptide Holds Out Hope For New Antiretroviral Drugs. Kingman, Sharon // BioWorld International;4/25/2007, Vol. 12 Issue 17, p1 

    The article reports on a natural peptide found in human blood that is capable of preventing the human immunodeficiency virus (HIV-1) from infecting human cells. Laboratory tests shoed that the peptide could inhibit strains of HIV-1 that are known to be drug-resistant. The strength of the...

  • Artesunate Dose Escalation for the Treatment of Uncomplicated Malaria in a Region of Reported Artemisinin Resistance: A Randomized Clinical Trial. Bethell, Delia; Se, Youry; Lon, Chanthap; Tyner, Stuart; Saunders, David; Sriwichai, Sabaithip; Darapiseth, Sea; Teja-Isavadharm, Paktiya; Khemawoot, Phisit; Schaecher, Kurt; Ruttvisutinunt, Wiriya; Lin, Jessica; Kuntawungin, Worachet; Gosi, Panita; Timmermans, Ans; Smith, Bryan; Socheat, Duong; Fukuda, Mark M. // PLoS ONE;2011, Vol. 6 Issue 5, p1 

    Background: The emergence of artemisinin resistance has raised concerns that the most potent antimalarial drug may be under threat. The currently recommended daily dose of artesunate (AS) is 4 mg/kg, and is administered for 3 days together with a partner antimalarial drug. This study...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics